Drug Shortage Report for TWINRIX JUNIOR
| Report ID | 80599 |
| Drug Identification Number | 02237548 |
| Brand name | TWINRIX JUNIOR |
| Common or Proper name | Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 360UNIT 10MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-04-02 |
| Estimated end date | 2019-05-16 |
| Actual end date | 2019-05-10 |
| Shortage status | Resolved |
| Updated date | 2019-05-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-04-05 | English | Compare |
| v2 | 2019-04-05 | French | Compare |
| v3 | 2019-05-10 | English | Compare |
| v4 | 2019-05-10 | French | Compare |
| v5 | 2019-05-11 | English | Compare |
Showing 1 to 5 of 5